NASDAQ:MNPR | Profit Breakdown | Monopar Therapeutics

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$6.64M-$5.31M
2026-03-31$0.00-$5.23M-$3.89M
2025-12-31-$6.16M-$5.2M
2025-09-30-$4.09M-$3.44M
2025-06-30-$3.23M-$2.45M
2025-03-31-$3.22M-$2.62M
2024-12-31-$11.07M-$10.93M
2024-09-30-$1.57M-$1.3M
2024-06-30-$1.79M-$1.72M
2024-03-31-$1.72M-$1.64M
2023-12-31-$1.91M-$1.81M
2023-09-30-$2.07M-$1.95M
2023-06-30-$2.33M-$2.2M
2023-03-31-$2.53M-$2.43M
2022-12-31-$2.91M-$2.9M
2022-09-30-$2.41M-$2.4M
2022-06-30-$2.76M-$2.76M
2022-03-31-$2.46M-$2.46M
2021-12-31-$2.68M-$2.68M
2021-09-30-$2.46M-$2.46M
2021-06-30-$2.09M-$2.08M
2021-03-31-$1.89M-$1.88M
2020-12-31-$2.26M-$2.13M
2020-09-30-$1.65M-$1.64M
2020-06-30-$1.46M-$1.45M
2020-03-31-$1.14M-$1.09M
2019-12-31$0.00-$1.22M-$1.21M
2019-09-30$0.00-$759,448.00-$736,080.00
2019-06-30$0.00-$932,109.00-$905,700.00
2019-03-31$0.00-$1.41M-$1.38M
2018-12-31$0.00-$926,358.00-$890,461.00
2018-09-30$0.00-$667,532.00-$640,184.00
2018-06-30$0.00-$667,532.00-$640,184.00
2018-03-31$0.00-$897,260.00-$876,347.00
2017-12-31$0.00-$736,800.00-$713,583.00
2017-09-30$0.00-$14.9M-$14.88M
2017-06-30$0.00-$594,957.00-$591,438.00
2017-03-31$0.00-$373,839.00-$372,915.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$0.00-$16.7M-$13.72M-$13.72M
2024-12-31$0.00-$16.16M-$15.59M-$15.59M
2023-12-31-$8.83M-$8.4M-$8.4M
2022-12-31-$10.54M-$10.52M
2021-12-31-$9.13M-$9.1M
2020-12-31-$6.51M-$6.3M
2019-12-31$0.00-$4.32M-$4.22M
2018-12-31$0.00-$3.33M-$3.3M-$3.23M
2017-12-31$0.00-$16.6M-$16.55M-$16.55M
2016-12-31$0.00-$1.19M-$1.19M